ArticleMolecular vision2025
Monocyte/macrophage-derived IL-15 activates STAT5 to trigger the EFNA1/NCOA2-positive feedback loop, facilitating retinal angiogenesis in high-glucose environments.
Article in Molecular vision, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Diabetic retinopathy (DR) is of the most prevalent complications among diabetic patients. The potential role of interleukin 15 (IL-15) in modulating immune cell function and angiogenesis has drawn considerable attention. Nevertheless, the precise mechanism through which IL-15 operates in DR remains elusive. Methods: The GSE185011 and GSE221521 data sets were harnessed to screen for upregulated genes in the blood and peripheral blood mononuclear cells (PBMCs) of patients with DR. The GSE236333 and GSE179568 data sets were used to identify upregulated genes in retinal tissues. In the clinical investigation, IL-15 was detected in T and B lymphocytes, as well as in monocytes/macrophages within the PBMCs of patients. Human retinal microvascular endothelial cells and human umbilical vein endothelial cells were either cocultured with the monocyte/macrophage cell line THP-1 under high-glucose (HG) conditions or treated with IL-15. Results: Among the three cell types in PBMCs, monocytes/macrophages exhibited the most substantial upregulation of IL-15 under HG conditions. In vitro, IL-15 secreted by THP-1 cells augmented the STAT5 in human retinal microvascular endothelial cells and human umbilical vein endothelial cells, thereby enhancing their angiogenic potential. Inhibition of STAT5 expression counteracted the proangiogenic effect of IL-15 on endothelial cells and diminished the expression of epithelial cell adhesion molecule 1 (EFNA1). After the knockdown of nuclear receptor coactivator 2 (NCOA2), the binding affinity of STAT5 to the EFNA1 gene promoter was significantly attenuated, and the influence of IL-15 on EFNA1 expression and angiogenesis was markedly reduced. Intriguingly, knockdown of either EFNA1 or NCOA2 led to a concurrent decrease in the expression of both genes in endothelial cells, suggesting a positive feedback regulatory loop between them. Conclusions: IL-15 secreted by monocytes/macrophages activates STAT5, which in turn induces a positive feedback regulation of the EFNA1/NCOA2 axis, ultimately promoting retinal angiogenesis under HG conditions.
Indexed as
Identifiers
41867368PMC13002957What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.